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Abstract The scientific evaluation of the antidiabetic
efficacy of aqueous extract of Trichosanthes dioica fruits
on streptozotocin-induced diabetic rats is being presented.
The graded doses of the extract, viz., 500, 750, 1,000, and
1,250 mg/kg body weight (bw), were administered orally,
and it was observed that the blood glucose concentration
decreased in a dose-dependent manner. The dose of
1,000 mg/kg bw showed the maximum fall of 23.8% and
19.1% in blood glucose level (BGL) during fasting BGL
and glucose tolerance test (GTT) studies, respectively, of
nondiabetic rats. Whereas in the case of subdiabetic and
mild diabetic models, the same dose showed reduction in
BGL of 22.0% and 31.4% during GTT. The study also
involves the first use of laser-induced breakdown spectros-
copy as a sensitive analytical tool to detect the elemental
profile responsible for the antidiabetic activity of aqueous
extract of T. dioica fruits that exhibits the antidiabetic
activity. High intensities of Ca, Mg, and Fe indicate large
concentrations of these elements in the extract, since
according to Boltzmann’s distribution law, intensities are
directly proportional to concentrations. The higher concen-
trations of these glycemic elements, viz. Ca, Mg, and Fe,
are responsible for the antidiabetic potential of T. dioica as
well as other plant already reported by our research group.
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Introduction
Diabetes mellitus, characterized by hyperglycemia, is the
most common metabolic disorder considered among five
leading causes of death in the world.1,2 It is a serious illness
with multiple complications and premature mortality,
accounting for at least 10% of total health care expenditure
in many countries.3 The long-term hyperglycemic condi-
tions lead to numerous alterations in cell membrane
properties; examples are the enhanced rigidity, permeability
to cations, and the absolute magnitude of the transmem-
brane potential.4 Because the synthetic drugs have undesir-
able side effects or contraindications, the World Health
Organization has recommended the evaluation of traditional
plant treatments for diabetes.5 Hypoglycemic sulfonylureas
such as glibenclamide can increase pancreatic insulin
secretion from the existing β-cells in streptozotocin
(STZ)-induced diabetes by membrane depolarization and
stimulation of Ca2+ influx, an initial key step in insulin
secretion.6 Moreover, natural plant drugs are considered
less toxic and exhibit the side effects less pronounced than
those of synthetic drugs.7–9 Hypoglycemic effects have
been reported in some plants that contain terpenoids, iridoid
glycosides, flavonoids, and other phenolic compounds.10
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Trichosanthes dioica Roxb. (family: Cucurbitaceae),
commonly known as “Sespadula” in English and “Parwal”
in Hindi, is widely grown throughout India.11 Fruits of this
plant are used as vegetable in Indian traditional food system
from time immemorial. Besides fruits, other parts of the
plant, such as the leaves and tender shoots, have also been
used in the traditional system of medicine since ancient
times.12–14 Some specific medicinal properties have been
identified, viz., hypocholesterolemic, hypoglyceridimic,
and hypophospholipemic when shade-dried fruits were
mixed in the food of nondiabetic animals.12,15 Most
recently, its seeds and leaves have also been found as
antidiabetic agents by our research group.16,17 It also serves
as a rich source of vitamin C.12
The present study is designed to validate scientifically
the use of glycemic elements of T. dioica in folklore
medicines for managing diabetes by evaluating its glycemic
potential. The impact was observed on blood glucose level
(BGL) of nondiabetic and STZ-induced subdiabetic and
mild diabetic rats. The parameters such as fasting blood
glucose level (FBG) and glucose tolerance test (GTT) were
taken in consideration as valuable scientific tools validating
the ethnopharmacological profile of T. dioica fruits.
Moreover, the present study describes the laser-induced
breakdown spectroscopy (LIBS)-based detection of major
and minor elements present in T. dioica (pointed gourd)
fruits responsible for its antidiabetic potential based on
screening of the best set of glycemic elements involved.
Experimental
Material Preparation
Fresh unripe fruits (6 kg) of T. dioica were purchased from
the local market of Allahabad (India) and authenticated by
Prof. Satya Narayan, Taxonomist, Department of Botany,
University of Allahabad, India. A voucher specimen
(AA512) has been submitted. The fruits were cut into
small pieces and shade-dried. The dried pieces were
mechanically crushed and extracted with distilled water
using soxhlet at boiling temperature (100°C) up to 36 h.
The extract was filtered and concentrated in the rotatory
evaporator at 35±5°C under reduced pressure to obtain
semisolid material, which was then lyophilized to get a
powder (yield 14.9% w/w).
Experimental Animals and Induction of Diabetes
Experiments were performed on 6–8-week-old, healthy,
male albino Wistar rats, the body weight of which ranged
from 150 to 200 g. Animals obtained from the National
Institute of Communicable Diseases, New Delhi, India,
were housed under standard environmental conditions (25±
2°C temperature, 50±5% humidity with a 12 h of dark and
light cycle each) and maintained with free access of water
and a standard laboratory diet (carbohydrates 30%, proteins
22%, lipids 12%, and vitamins 3%) ad libitum. The study
was approved by the Institutional Ethical Committee.
Diabetes was induced by a single intraperitoneal injec-
tion of freshly prepared STZ (purchased from Sigma
Aldrich Chem. Co. USA) 55 mg/kg bw in 0.1 m citrate
buffer (pH 4.5) to a group of overnight-fasted rats. After
3 days of STZ administration, FBG levels were estimated
and postprandial blood glucose level (PPG) checked
regularly up to stable hyperglycemia, i.e., 1 week after
STZ injection. Animals having marked hyperglycemia were
selected for the study17 and depending upon their BGL
divided into two groups, i.e.:
1. Subdiabetic rats with FBG 80–120 mg/dl and PPG
more than 210 mg/dl
2. Mild diabetic rats with FBG 120–250 mg/dl and PPG
more than 350 mg/dl
Estimation of Glycemic Potential
Blood glucose level was estimated by glucose oxidase
method18 using standard kit (Bayer Diagnostics India
Limited). The percentage variation of glycemia for each
group was calculated in relation to initial (0 h) values for
FBG studies19 and in relation to control values for GTT
studies.20
FBG % variation of glycemia ¼ G0  GX
G0
 100
G0 is the initial value; GX is the value at 2, 4, and 6 h.
GTT % variation of glycemia ¼ GC  Gy
GC
 100
GC is the control value; Gy is the value at 1 and 2 h
Experimental Design
Initial screening of the aqueous extract was performed by
conducting FBG and GTT studies with a range of variable
doses in nondiabetic healthy rats for hypoglycemic activity
and in subdiabetic as well as mild diabetic rats for
antidiabetic activity.
Five groups of six rats each fasted overnight were used
in each experiment of FBG and GTT studies of nondiabetic,
subdiabetic, and mild diabetic animals. Group 1 served as
untreated control receiving vehicle (distilled water), where-
as the animals of groups 2, 3, 4, and 5 received the extract
suspended in distilled water at doses of 500, 750, 1,000,
and 1,250 mg/kg, respectively. For FBG studies of
18 Food Biophysics (2010) 5:17–23
nondiabetic and subdiabetic as well as mild diabetic rats,
blood samples were collected from tail vain before giving
the extract and 2, 4, 6, and 8 h after giving the extract.
For GTT studies on nondiabetic rats, extract was given
orally after taking FBG; then, its effect on FBGwas studied up
to 90min. The BGL value at 90minwas treated as “0”-h value
for GTT. The animals were then orally administrated with
2 g/kg of glucose, and their glucose tolerance was studied
at 1-h interval for another 3 h, and the values were
considered as 1-, 2-, and 3-h values.
The antidiabetic effect of aqueous extract of T. dioica
fruits in subdiabetic and mild diabetic rats was also
assessed by improvement in glucose tolerance in the same
way as above. In this study, one additional group (group 6)
was taken as a positive control, and the results were
compared with this group of rats, treated with 250 mg/kg of
tolbutamide (hypoglycemic agent).
Detection of Trace Elements
A schematic diagram of the experimental setup for
recording of LIBS spectra is shown in Fig. 1. The LIBS
spectra of T. dioica fruit extract powder dissolved in
distilled water were recorded to identify the presence of
the best set of elements responsible for its antidiabetic
efficacy. The four-channel spectrometer equipped with
charge-coupled device (CCD; Ocean optics LIBS 2000+)
comprising the four gratings was used to get the dispersed
light from the plasma. A pulsed laser beam from a Q-
switched Nd:YAG laser (Continuum Surellite III-10) was
focused on the sample using a converging lens (Quartz) of
30-cm focal length; the temperature of the locally heated
region rose rapidly and resulted in plasma formation on the
sample’s surface. The light emitted from microplasma was
collected using an optical fiber tip placed in the vertical
Fig. 1 LIBS experimental setup
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Fig. 2 Laser-induced break-
down spectra of T. dioica in the
spectral range 200–450 nm
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plane (at 45° with respect to the laser beam) and finally fed
into the entrance slit of the multichannel spectrometer
(Ocean Optics LIBS2000+) equipped with CCD and four
gratings. The spectra presented in Figs. 2 and 3 are the
averages of 100 scans (100 shots). The first three gratings
with 0.1-nm resolution are designed to cover the wave-
length range from 200 to 310, 310 to 400, and 400 to
510 nm, respectively, while the fourth grating (resolution
0.75 nm), termed a broadband grating, covered the 200–
1,100-nm interval. All four gratings were used simulta-
neously to record the LIBS spectra. In the case of aqueous
extract of T. dioica, the LIBS spectra were recorded at the
repetition rate of 2 Hz and 175-mJ laser energy. The
solution was prepared by dissolving 1.0 g of lyophilized
material in 10 ml of distilled water.
Results and Discussion
In the last few years, a number of new oral agents (originating
from natural products) for the treatment of type 2 diabetes have
been introduced, in the hopes of achieving a better glycemic
control. Metformin, a biguanide, is a plant product, which is in
clinical use for the treatment of type 2 diabetes for over
40 years. This compound enhances the sensitivity of both
hepatic and peripheral tissues to insulin and inhibits gluco-
neogenesis in the liver.21 Table 1 describes the hypoglycemic
effect of a single oral administration of variable doses (500,
750, 1,000, and 1,250 mg/kg) of aqueous fruit extract in
nondiabetic healthy rats. A regular fall and the maximum fall
observed in BGLwere 23.8%with the dose of 1,000mg/kg bw.
Table 2 deals with the study of aqueous extract of T.
dioica fruits on glucose tolerance of nondiabetic healthy
rats, and the maximum fall observed at 3 h after glucose
administration was 19% when the dose was 1,000 mg/kg.
Table 3 demonstrates the antidiabetic effect of aqueous
extract of T. dioica fruits on subdiabetic and mild diabetic
animals, respectively. Different doses of aqueous extract as
mentioned above along with the standard drug tolbutamide
250 mg/kg were given orally to the groups as defined in the
experimental design. In the case of subdiabetic rats, the fall of
13.7%, 17.01%, 22.0%, and 16.3% in BGL was observed
after 3 h of glucose administration with the doses of 500, 750,
1,000, and 1,250 mg/kg, respectively. The highest fall was
observed with the dose of 1,000 mg/kg which is comparable
with 24.1% observed with the dose of 250 mg/kg of
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Fig. 3 Laser-induced break-
down spectra of T. dioica in the
spectral range 200–900 nm
Blood glucose levels (mg/dl)
Pretreatment Post treatment (h)
Experimental
groups
Treatment
(mg/kg bw)
FBG 1.5 3.0 4.5 6.0
Control Distilled water 69.5±3.9 69.3±3.2 70.0±4.6 70.1±3.8 69.2±4.2
Extract 500 70.0±3.2 68.8±4.4 66.1±4.6 62.4±5.1 60.1±3.8*
Extract 750 68.2±3.2 65.9±4.4 62.1±4.6 58.7±5.1 55.6±3.8*
Extract 1,000 71.4±3.2 68.1±4.4 63.5±4.6 58.9±5.1 54.3±3.8*
Extract 1,250 72.1±4.6 70.4±4.2 67.1±4.8 65.8±3.7* 60.4±4.5*
Table 1 Effect of graded
dose of T. dioica fruit aqueous
extract on BGL of normoglyce-
mic rats (mean ± SD)
*P<0.05 as compared with
initial
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tolbutamide. In the case of mild diabetic animals, the fall
observed was 16.4%, 29.7%, 31.3%, and 28.6% during GTT
with the doses of 500, 750, 1,000, and 1,250 mg/kg,
respectively. However, the doses of 250 mg/kg of tolbuta-
mide reduced BGL by 31.5% which is practically the same as
obtained with the dose of 1,000 mg/kg.
The spectra of T. dioica fruit extract, shown in Figs. 2
and 3, were taken at optimized experimental conditions. It
clearly revealed the presence of Mg, Fe, Na, K, Zn, Ca, H,
O, C, and N elements in the spectral range from 200 to
900 nm. According to the Boltzmann’s distribution law,
intensity is directly related to concentration.22
ln
Ikil
Akigk
¼  Ek
kBT
þ ln CsF
UsðTÞ ð1Þ
where kB is the Boltzmann constant; 1 is the wavelength of
the transition; Aki is the transition probability; gk is
degeneracy factor; Ikil represents the measured integral line
intensity; Cs is the concentration of the emitting atomic
species; Us (T) is the partition function of that specie at
plasma temperature (T), and F is an experimental parameter
which takes into account the optical efficiency of the
collection system. The concentration of a species is
evaluated from the intercept of the Boltzmann plot (by
using Eq. 1).
Therefore, the intensity of the observed spectral lines
corresponding to major and minor elements present in the
extract is not only indicative for their concentration, but it
also assists in defining their role in diabetes-induced
oxidative stress management. The ratio of intensities of the
detected elements (Mg, Fe, Na, K, Zn, Ca, C, H, O, and N) to
the intensities of reference lines (C and O that are essential
elements of plant materials) was estimated to evaluate their
concentration in proportion. Since gratings with different
resolutions were used, the whole spectrum was divided in
two sections: the first (resolution 0.1 nm) covered the
wavelength range from 200 to 510 nm and the second
Blood glucose levels (mg/dl)
Pretreatment Post treatment (h)
Experimental
groups
Treatment
(mg/kg bw)
FBG 1 2 3 4 5
Control Distilled water 74.3±4.7 73.9±3.6 74.5±4.1 108.3±4.6 98.6±3.2 92.4±4.3
Treated 1 500 68.1±42 67.3±5.1 66.1±4.6 92.4±4.9 84.1±4.4* 78.4±3.8
Treated 2 750 69.1±3.5 68.8±4.9 68.2±3.6 90.8±4.9 82.5±4.6* 76.1±3.7
Treated 3 1,000 70.1±4.2 68.4±4.3 65.8±5.6 90.1±4.9 80.3±4.8* 74.6±4.4
Treated 4 1,250 68.9±4.6 68.0±3.2 67.2±3.8 92.5±4.5* 83.4±3.8* 78.1±3.9
Table 2 Effect of graded dose
of T. dioica fruit aqueous extract
on BGL during GTT of normo-
glycemic rats (mean ± SD)
*P<0.05 as compared with
control
Table 3 Effect of variable doses of T. dioica on GTT of sub diabetic and mild diabetic rats (mean ± SD)
Groups (treatment and doses) FBG 0h 1h 2h 3h
BGL of subdiabetic animals (mg/dl)
I (control, D W) 85.5±4.3 84.8±4.7 259.8±3.9 190.2±4.2 131.5±3.6
II (extract, 500 mg/kg) 84.3±5.1 74.6±4.4* 241.0±4.5* 166.5±4.2* 113.4±4.5*
III (extract, 750 mg/kg) 95.9±4.2 94.5±4.7 233.1±4.3* 161.7±4.4** 109.2±4.6***
IV (extract, 1,000 mg/kg) 91.5±4.3 85.6±5.0 203.5±4.8* 149.0±5.1** 102.5±4.8**
IV (extract, 1,250 mg/kg) 93.1±4.1 90.2±4.5 204.9±4.1 162.8±4.7 110.4±4.2
V (tolbutamide, 250 mg/kg) 85.7±4.5 79.6±4.6 200.4±4.9* 145.3±4.3** 99.8±4.4**
BGL of mild diabetic animals (mg/dl)
I (control, D W) 178.9±3.9 179.2±5.2 398.4±4.7 322.7±5.4 284.6±5.3
II (extract, 500 mg/kg) 176.3±4.5 171.5±5.6 331.2±4.9* 272.7±4.7* 236.7±4.9*
III (extract, 750 mg/kg) 169.4±4.7 166.5±4.8 316.8±5.1* 256.1±5.4** 199.9±5.2***
IV (extract, 1,000 mg/kg) 165.2±5.2 141.5±5.1 259.1±4.6** 214.7± 4.8** 186.9±5.7*
IV (extract, 1,250 mg/kg) 166.6±5.1 159.3±5.3 258.5±5.1 217.4±4.5* 192.4±4.3**
V (tolbutamide, 250 mg/kg) 171.4±4.9 151.3±4.7 259.4±4.6 112.9±4.3 192.1±4.1
*P<0.05; **P<0.001; ***P<0.001, as compared with control
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(0.75-nm resolution) spanning the wavelength range be-
tween 510 and 1,100 nm. To find the intensity ratios of
spectral lines, the C line at 247.88 nm (as a reference line for
the spectral range of λ 200–510 nm) and the O line at
844.10 nm (as the reference line for spectral wavelength
range of 500–1,100) nm have been selected. Calculated
intensity ratios of Zn/C, Fe/C, Mg/C, Ca/C, K/O, Na/O, H/O,
and N/O are given in Tables 4 and 5. A broad variety of
structurally distinct molecules stimulate insulin secretion
from pancreatic β-cells by different mechanisms of action.
Esters of succinic acid, the new potent insulin secreta-
gogues,23–25 have been proposed as a novel antidiabetic
agent for type 2 diabetes. It has been previously shown that
succinic acid ester can be taken up and metabolized by
pancreatic β cells, leading to increased proinsulin biosyn-
thesis,26 insulin secretion, and lowered blood glucose.27,28
The possible mechanism of action of the aforesaid elements
could be correlated with the reminiscent effect of the
hypoglycemic sulfonylureas that promote insulin secretion
by closure of K+-ATP channels, membrane depolarization,
and stimulation of Ca2+ influx, an initial key step in insulin
secretion,27,28 also protect pancreatic islets in vivo and in
vitro against STZ.29 Recently, we have found in our lab that
Mg and Ca manage the blood glucose levels and also
restore the antioxidant activity in type 2 diabetic rats.30–34
From the outcome of this study, it can be conclusively
stated that the higher concentrations of Ca++, Mg++, and
Fe++, as reflected by their intensities, are responsible for
glycemic potential of T. dioica. Further studies to establish
the absolute concentrations of trace elements needed for
optimum glycemic activity in diabetic management are in
progress. In addition, the results obtained demonstrate
clearly that LIBS can be considered as a scientific and
reliable monitor for detection of glycemic elements in
herbs. As such, it can substantially help in the management
of diabetes mellitus by screening of various identified
antidiabetic medicinal plants for their glycemic elements.
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